Skip to content

Threat Status

WATCH: China is trying to isolate and threatening to invade Taiwan

Advertisement

FILE - This Aug. 2, 2018, file photo shows the U.S. Food and Drug Administration building behind FDA logos at a bus stop on the agency's campus in Silver Spring, Md. Investors are driving shares of drug developer BioMarin down by a third after U.S. regulators rejected its potentially game-changing gene therapy for hemophilia A patients. The FDA's rejection late Tuesday, Aug. 18, 2020, means BioMarin will have to complete an ongoing late-stage patient study. (AP Photo/Jacquelyn Martin, File)

FILE - This Aug. 2, 2018, file photo shows the U.S. Food and Drug Administration building behind FDA logos at a bus stop on the agency's campus in Silver Spring, Md. Investors are driving shares of drug developer BioMarin down by a third after U.S. regulators rejected its potentially game-changing gene therapy for hemophilia A patients. The FDA's rejection late Tuesday, Aug. 18, 2020, means BioMarin will have to complete an ongoing late-stage patient study. (AP Photo/Jacquelyn Martin, File)

Featured Photo Galleries

Murphy_Giants-2.jpg

Jayden Daniels gets first NFL win as Commanders beat Giants

Led by a single-game franchise-record seven field goals from kicker Austin Seibert, the Washington Commanders defeated the New York Giants 21-18 at Northwest Stadium, Landover, Md., September 15, 2024. (Photos by Brian Murphy for the Washington Times)